Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 1.11x is 64% below its estimated 4-year average of 3.05x, near the low end of its estimated 4-year range (0.01x–17.84x).
As of 2026-10-06T15:37:00.896Z. 3.64% below its estimated 12-month average of 1.15x.
Calculation as of: 2026-10-06T15:37:00.896Z.
Quote observation: 2026-10-06T15:35:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 767633254d5919bd59cda52a5696942c7bb29bc9076435c5b91744fa0c767718
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
1.11x
EV/SALES RATIO AVG TTM
1.15x
EV/SALES RATIO AVG 3Y
3.38x
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-3.64%
CURRENT VS 3Y AVG
-67.20%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.19x
median of 442 covered companies
CURRENT VS SECTOR MEDIAN
-73.51%
vs the sector median at left
Werewolf Therapeutics, Inc.
Market Cap
$45.22M
EV/Sales Ratio
1.11x
TTM Avg
1.15x
3Y Avg
3.38x
5Y Avg
N/A
Market Cap
$44.26M
EV/Sales Ratio
1.34x
TTM Avg
8.61x
3Y Avg
25.49x
5Y Avg
46.59x
Market Cap
$44.50M
EV/Sales Ratio
N/A
TTM Avg
0.79x
3Y Avg
3.53x
5Y Avg
4.11x
Market Cap
$45.99M
EV/Sales Ratio
3.42x
TTM Avg
18.20x
3Y Avg
28.24x
5Y Avg
65.32x
Market Cap
$48.05M
EV/Sales Ratio
1.34x
TTM Avg
1.40x
3Y Avg
1.67x
5Y Avg
2.03x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $45.22M | 1.11x | 1.15x | 3.38x | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.26M | 1.34x | 8.61x | 25.49x | 46.59x |
| BioStem Technologies, Inc. (BSEM)vs › | $44.50M | N/A | 0.79x | 3.53x | 4.11x |
| DarioHealth Corp. (DRIO)vs › | $45.99M | 3.42x | 18.20x | 28.24x | 65.32x |
| CVRx, Inc. (CVRX)vs › | $43.39M | 0.62x | 2.63x | 4.55x | 5.21x |
| Lite Strategy, Inc. (LITS)vs › | $48.25M | N/A | N/A | N/A | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.05M | 1.34x | 1.40x | 1.67x | 2.03x |
| Precipio, Inc. (PRPO)vs › | $41.92M | 1.54x | 1.77x | 1.07x | 1.40x |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.78M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $49.79M | 5.78x | 2.45x | 4.17x | 10.47x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 1.11x |
| 2026-10-02 | 1.10x |
| 2026-10-01 | 0.99x |
| 2026-09-30 | 1.09x |
| 2026-09-29 | 1.06x |
| 2026-09-28 | 1.11x |
| 2026-09-25 | 1.17x |
| 2026-09-24 | 1.22x |
| 2026-09-23 | 1.24x |
| 2026-09-22 | 1.23x |
| 2026-09-21 | 1.22x |
| 2026-09-18 | 1.19x |
| 2026-09-17 | 1.18x |
| 2026-09-16 | 1.08x |
| 2026-09-15 | 1.22x |
| 2026-09-14 | 1.17x |
| 2026-09-11 | 1.23x |
| 2026-09-10 | 1.24x |
| 2026-09-09 | 1.19x |
| 2026-09-08 | 1.22x |
| 2026-09-04 | 1.19x |
| 2026-09-03 | 1.14x |
| 2026-09-02 | 1.26x |
| 2026-09-01 | 1.17x |
| 2026-08-31 | 1.13x |
| 2026-08-28 | 1.14x |
| 2026-08-27 | 1.20x |
| 2026-08-26 | 1.24x |
| 2026-08-25 | 1.01x |
| 2026-08-24 | 1.00x |
| 2026-08-21 | 0.97x |
| 2025-08-14 | 3.63x |
| 2025-08-13 | 4.80x |
| 2025-08-04 | 0.49x |
| 2025-07-29 | 2.84x |
| 2025-07-28 | 4.80x |
| 2025-07-25 | 5.19x |
| 2025-07-24 | 5.59x |
| 2025-07-23 | 6.37x |
| 2025-07-22 | 6.76x |
| 2025-07-21 | 6.76x |
| 2025-07-18 | 7.16x |
| 2025-07-17 | 6.76x |
| 2025-07-16 | 4.80x |
| 2025-07-15 | 3.23x |
| 2025-07-14 | 2.45x |
| 2025-06-24 | 0.88x |
| 2025-06-23 | 0.88x |
| 2025-06-18 | 0.49x |
| 2025-06-16 | 2.84x |
| 2025-06-12 | 2.45x |
| 2025-06-11 | 0.10x |
| 2025-06-10 | 4.02x |
| 2025-06-09 | 7.16x |
| 2025-06-06 | 7.55x |
| 2025-06-05 | 0.10x |
| 2025-06-04 | 3.23x |
| 2025-06-03 | 5.19x |
| 2025-05-29 | 2.06x |
| 2024-11-29 | 0.40x |
| 2024-11-27 | 0.01x |
| 2024-11-25 | 0.40x |
| 2024-11-13 | 1.05x |
| 2024-11-12 | 2.34x |
| 2024-11-11 | 2.98x |
| 2024-11-08 | 4.27x |
| 2024-11-06 | 0.81x |
| 2024-11-01 | 1.00x |
| 2024-10-31 | 1.38x |
| 2024-10-30 | 1.99x |
| 2024-10-29 | 2.13x |
| 2024-10-28 | 3.25x |
| 2024-10-25 | 3.44x |
| 2024-10-24 | 3.72x |
| 2024-10-23 | 5.32x |
| 2024-10-22 | 6.39x |
| 2024-10-21 | 2.74x |
| 2024-09-19 | 0.63x |
| 2024-09-13 | 0.35x |
| 2024-08-28 | 0.06x |
| 2024-08-27 | 0.06x |
| 2024-08-26 | 1.61x |
| 2024-08-23 | 0.58x |
| 2024-08-01 | 0.48x |
| 2024-07-31 | 0.35x |
| 2024-07-30 | 0.86x |
| 2024-07-29 | 1.45x |
| 2024-07-26 | 1.58x |
| 2024-07-25 | 1.61x |
| 2024-07-24 | 1.63x |
| 2024-07-23 | 2.12x |
| 2024-07-22 | 1.61x |
| 2024-07-19 | 1.56x |
| 2024-07-18 | 1.69x |
| 2024-07-17 | 1.97x |
| 2024-07-16 | 2.15x |
| 2024-07-15 | 1.92x |
| 2024-07-12 | 1.48x |
| 2024-07-11 | 1.61x |
| 2024-07-10 | 0.22x |
| 2024-07-09 | 0.58x |
| 2024-07-08 | 0.17x |
| 2024-07-03 | 0.07x |
| 2024-07-01 | 0.61x |
| 2024-06-28 | 0.84x |
| 2024-06-27 | 1.02x |
| 2024-06-26 | 0.58x |
| 2024-06-25 | 0.58x |
| 2024-06-24 | 1.27x |
| 2024-06-21 | 1.97x |
| 2024-06-20 | 1.48x |
| 2024-06-18 | 1.99x |
| 2024-06-17 | 2.61x |
| 2024-06-14 | 2.30x |
| 2024-06-13 | 2.92x |
| 2024-06-12 | 2.45x |
| 2024-06-11 | 2.79x |
| 2024-06-10 | 2.92x |
| 2024-06-07 | 3.53x |
| 2024-06-06 | 3.56x |
| 2024-06-05 | 3.79x |
| 2024-06-04 | 3.92x |
| 2024-06-03 | 4.81x |
| 2024-05-31 | 7.84x |
| 2024-05-30 | 8.33x |
| 2024-05-29 | 7.64x |
| 2024-05-28 | 7.30x |
| 2024-05-24 | 7.10x |
| 2024-05-23 | 7.82x |
| 2024-05-22 | 7.12x |
| 2024-05-21 | 7.41x |
| 2024-05-20 | 6.84x |
| 2024-05-17 | 6.69x |
| 2024-05-16 | 7.10x |
| 2024-05-15 | 7.02x |
| 2024-05-14 | 7.23x |
| 2024-05-13 | 6.02x |
| 2024-05-10 | 7.53x |
| 2024-05-09 | 8.87x |
| 2024-05-08 | 8.64x |
| 2024-05-07 | 9.25x |
| 2024-05-06 | 9.92x |
| 2024-05-03 | 7.00x |
| 2024-05-02 | 7.02x |
| 2024-05-01 | 6.91x |
| 2024-04-30 | 7.31x |
| 2024-04-29 | 8.08x |
| 2024-04-26 | 8.24x |
| 2024-04-25 | 7.25x |
| 2024-04-24 | 7.58x |
| 2024-04-23 | 7.68x |
| 2024-04-22 | 7.03x |
| 2024-04-19 | 6.69x |
| 2024-04-18 | 6.63x |
| 2024-04-17 | 6.58x |
| 2024-04-16 | 6.15x |
| 2024-04-15 | 5.93x |
| 2024-04-12 | 4.47x |
| 2024-04-11 | 5.16x |
| 2024-04-10 | 5.57x |
| 2024-04-09 | 5.68x |
| 2024-04-08 | 5.73x |
| 2024-04-05 | 6.72x |
| 2024-04-04 | 6.87x |
| 2024-04-03 | 6.91x |
| 2024-04-02 | 6.98x |
| 2024-04-01 | 7.57x |
| 2024-03-28 | 7.75x |
| 2024-03-27 | 7.51x |
| 2024-03-26 | 6.94x |
| 2024-03-25 | 6.89x |
| 2024-03-22 | 7.02x |
| 2024-03-21 | 6.59x |
| 2024-03-20 | 7.07x |
| 2024-03-19 | 6.76x |
| 2024-03-18 | 6.91x |
| 2024-03-15 | 7.13x |
| 2024-03-14 | 7.07x |
| 2024-03-13 | 7.27x |
| 2024-03-12 | 7.97x |
| 2024-03-11 | 7.88x |
| 2024-03-08 | 7.80x |
| 2024-03-07 | 6.33x |
| 2024-03-06 | 6.72x |
| 2024-03-05 | 6.44x |
| 2024-03-04 | 6.51x |
| 2024-03-01 | 6.67x |
| 2024-02-29 | 6.56x |
| 2024-02-28 | 5.79x |
| 2024-02-27 | 7.94x |
| 2024-02-26 | 7.16x |
| 2024-02-23 | 7.22x |
| 2024-02-22 | 6.16x |
| 2024-02-21 | 6.15x |
| 2024-02-20 | 6.34x |
| 2024-02-16 | 6.52x |
| 2024-02-15 | 5.70x |
| 2024-02-14 | 5.25x |
| 2024-02-13 | 5.11x |
| 2024-02-12 | 5.46x |
| 2024-02-09 | 6.15x |
| 2024-02-08 | 6.55x |
| 2024-02-07 | 5.72x |
| 2024-02-06 | 5.98x |
| 2024-02-05 | 5.39x |
| 2024-02-02 | 4.47x |
| 2024-02-01 | 3.57x |
| 2024-01-31 | 3.39x |
| 2024-01-30 | 3.79x |
| 2024-01-29 | 3.76x |
| 2024-01-26 | 3.00x |
| 2024-01-25 | 2.84x |
| 2024-01-24 | 2.68x |
| 2024-01-23 | 2.41x |
| 2024-01-22 | 2.68x |
| 2024-01-19 | 2.84x |
| 2024-01-18 | 3.17x |
| 2024-01-17 | 3.50x |
| 2024-01-16 | 3.67x |
| 2024-01-12 | 3.96x |
| 2024-01-11 | 3.93x |
| 2024-01-10 | 4.01x |
| 2024-01-09 | 3.92x |
| 2024-01-08 | 4.04x |
| 2024-01-05 | 4.40x |
| 2024-01-04 | 4.25x |
| 2024-01-03 | 3.00x |
| 2024-01-02 | 3.40x |
| 2023-12-29 | 2.32x |
| 2023-12-28 | 2.72x |
| 2023-12-27 | 2.36x |
| 2023-12-26 | 1.87x |
| 2023-12-22 | 1.44x |
| 2023-12-21 | 1.08x |
| 2023-12-20 | 0.96x |
| 2023-12-19 | 1.14x |
| 2023-12-18 | 1.12x |
| 2023-12-15 | 1.12x |
| 2023-12-14 | 0.94x |
| 2023-12-13 | 0.85x |
| 2023-12-12 | 0.60x |
| 2023-12-11 | 0.69x |
| 2023-12-08 | 0.99x |
| 2023-12-07 | 1.03x |
| 2023-12-06 | 0.90x |
| 2023-12-05 | 0.72x |
| 2023-12-04 | 0.78x |
| 2023-12-01 | 0.51x |
| 2023-11-30 | 0.37x |
| 2023-11-29 | 0.53x |
| 2023-11-28 | 0.44x |
| 2023-11-27 | 0.47x |
| 2023-11-24 | 0.31x |
| 2023-11-22 | 0.27x |
| 2023-11-21 | 0.26x |
| 2023-11-20 | 0.40x |
| 2023-11-17 | 0.16x |
| 2023-11-16 | 0.08x |
| 2023-11-15 | 0.02x |
| 2023-11-14 | 0.02x |
Showing the most recent 260 of 386 data points. The chart above shows the full history.
